Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Administration of Rapidly Generated EBV-Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01555892
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:19.217596+00:00
Published At
2026-03-02T00:00:00+00:00
Record Updated At
2026-03-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hodgkin\u0027s Disease", "Non-Hodgkin\u0027s Lymphoma", "Lymphoproliferative Disease", "Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-02"
protocolSection.identificationModule.nctId
"NCT01555892"
protocolSection.identificationModule.officialTitle
"Administration of Rapidly Generated EBV-Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive Lymphoma"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hodgkin's Disease (protocolSection.conditionsModule.conditions)
  • Non-Hodgkin's Lymphoma (protocolSection.conditionsModule.conditions)
  • Lymphoproliferative Disease (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.